Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
Conditions
Prostate Cancer · Prostate Cancer (Adenocarcinoma) · Prostate Cancer Metastatic Disease · Prostate Cancer Recurrent · Prostate Carcinoma · Prostate Neoplasm · Prostate Adenocarcinoma · Prostate Cancer With Bone Metastasis · Vasomotor Disturbance · Vasomotor Symptoms · Vasomotor Symptoms (VMS) · Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men · Vasomotor Symptoms; Hot Flashes · Androgen Deprivation Therapy · Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma · Androgen-deprivation Therapy · Hot Flashes · Hot Flushes · Hot Flushes and/or Sweats
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Shehzad Basaria, MD)
Study leads
Shehzad S Basaria, MD
Principal Investigator
Brigham and Women's Hospital